FDA approves AI tool to predict breast cancer risk

The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. Dr. Jeff Elton, the vice chairman at AI health-tech company ConcertAI joined LiveNOW's Christy Matino to discuss how it works.